Evidence map›Paper›PMID 34768619›Full record

ArticleJournal of clinical medicine2021

Temporal Relationship between Atrial Fibrillation and Heart Failure Development Analysis from a Nationwide Database.

Yves Cottin, Brahim Maalem Ben Messaoud, Antoine Monin, Pierre Guilleminot, Arnaud Bisson, Jean-Christophe Eicher, Alexandre Bodin, Julien Herbert, Yves Juillière, Marianne Zeller and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yves CottinCardiology Department, University Hospital Center Dijon-Bourgogne, 21000 Dijon, France.
Brahim Maalem Ben MessaoudCardiology Department, University Hospital Center Dijon-Bourgogne, 21000 Dijon, France.
Antoine MoninCardiology Department, University Hospital Center Dijon-Bourgogne, 21000 Dijon, France.
Pierre GuilleminotCardiology Department, University Hospital Center Dijon-Bourgogne, 21000 Dijon, France.ORCID 0000-0003-0837-9150
Arnaud BissonCardiology Department, University Hospital Center Trousseau and University François Rabelais, 37000 Tours, France.
Jean-Christophe EicherCardiology Department, University Hospital Center Dijon-Bourgogne, 21000 Dijon, France.
Alexandre BodinCardiology Department, University Hospital Center Trousseau and University François Rabelais, 37000 Tours, France.
Julien HerbertCardiology Department, University Hospital Center Trousseau and University François Rabelais, 37000 Tours, France.
Yves JuillièreCardiology Department, University Hospital Center, 54000 Nancy, France.
Marianne ZellerPhysiopathologie et Epidémiologie Cérébro-Cardiovasculaires (PEC2), Equipe d'Accueil (EA 7460), University of Bourgogne Franche Comté, 21000 Dijon, France.ORCID 0000-0002-5763-4579
Laurent FauchierCardiology Department, University Hospital Center Trousseau and University François Rabelais, 37000 Tours, France.ORCID 0000-0002-9267-1658
Université de Tours · FRPhysiopathologie et Epidémiologie Cérébro-Cardiovasculaires · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Atrial fibrillation (AF) and heart failure (HF) often co-exist and are closely intertwined, each condition worsening the other. The temporal relationships between these two disorders have not yet been fully explored. We aimed to address the outcomes of patients hospitalized with HF and AF based on the chronology of the onset of the two disorders. Methods From the administrative database for the whole French population, we identified 1,349,638 patients diagnosed with both AF and HF between 2010 and 2018; 956,086 of these AF patients developed HF first (prevalent HF), and 393,552 developed HF after AF (incident HF). The outcome analysis (all-cause death, cardiovascular (CV) death, ischemic stroke or hospitalization for HF) was performed with follow-up starting at the time of last event between AF or HF in the whole cohort and in 427,848 propensity score-matched patients. Results During follow-up (mean follow-up 1.6 ± 1.9 year), matched patients with prevalent HF had a higher risk of all-cause death (21.6 vs. 19.3%/year, hazard ratio (HR) 1.10, 95% CI 1.08-1.11), CV death (7.7 vs. 6.5%/year, HR 1.14, 95% CI 1.12-1.16) as well as re-hospitalization for HF (19.4 vs. 13.2%/year, HR 1.44, 95% CI 1.41-1.46) than those with incident HF. The risk for ischemic stroke was lower in prevalent HF than in incident HF (1.2 vs. 2.4%/year, HR 0.50, 95% CI 0.48-0.52). Conclusions We identified two distinct clinical entities: patients in whom HF preceded AF (prevalent HF) had higher mortality and higher risk of re-hospitalization for HF.

Indexed as

atrial fibrillationheart failureprognosis

Identifiers

PMID34768619
PMCPMC8585083
OpenAlexW3208445294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.